Breaking News

Bottled Botox Drives Cosmeceutical Growth

December 9, 2005

Consumers are avid for non-invasive alternatives to Botox and cosmetic surgery, driving a cosmeceuticals market destined to grow 8.5% to $5.1 billion by 2007, according to the Freedonia Group.
Even with the mainstreaming of cosmetic surgery, not everyone wants to take such drastic anti-aging measures.
“Companies are tapping into this market by creating products that simulate the effects of nip-and-tuck,” says Find/SVP analyst Vicki Stafford. “Faux tox” products are being offered by major high-end players such as Estée Lauder, Clinique and Lancôme, as well as by mass marketers L’Oréal and Olay, which is a subsidiary of Procter & Gamble, but the real growth has been in so-called “doctor brands;” i.e., skin care lines by dermatologists and plastic surgeons.
“Dermatologists’ products have credibility with consumers,” noted Ms. Stafford. The success of products like StriVectin-SD and lines by Fredric Brandt, Erno Laszlo and N.V. Perricone, among others, has meant 10% growth per year for this segment, stimulating a private label market for companies that help doctors develop their products, which include ingredients like green tea, retinol and Indian Chaulmoogra oil. And retailers have begun to stock more of these lines to help boost sales and expand their customer base. A host of celebrity clients hasn’t hurt either.
However, while these products simulate cosmetic surgery—reducing lines and plumping up tired skin cells—the results are temporary, so consumers may eventually opt for more permanent measures or move on to the next fountain-of-youth-in-a-bottle. In an increasingly crowded market, major players have better margins, and at retail, sales staff need to be educated in selling these more complex product lines.
While familiar brands such as Lancôme, Juvena, L’Oréal, La Prairie and Avon have already catered to the trend, some companies to watch among the dermatologists’ lines are Dr. Brandt, DDF Therapeutic, Murad, Dr. Gendler Skin Appointments, Erno Lazlo, N.V. Perricone, RéVive and StriVectin-SD, a stretch-mark product that registered sales in excess of $30 million in sales as a wrinkle cream.
While Sephora was one of the first chains to capitalize on doctor brands; Nordstrom, Henri Bendel, Blooming- dale’s, Bergdorf Goodman, Neiman Marcus and Lord & Taylor, which is part of May Department Stores, are among those following suit.
blog comments powered by Disqus
  • A Facial Bar Grows in Brooklyn

    A Facial Bar Grows in Brooklyn

    Christine Esposito, Associate Editor||October 24, 2016
    With three doors in Canada, Blitz Facial Bar opens its first US location in one of the hippest areas of New York.

  • Free and Clear

    Free and Clear

    Melissa Meisel, Associate Editor||October 17, 2016
    OY-L aims for zero-chemical skin care.

  • Coming Clean on a Host of Issues

    October 17, 2016
    Cleaning Products Conference is set for Nov. 9-11, 2016 in Washington DC.

  • Change Is in the Air

    Change Is in the Air

    Doreen Wang, BrandZ ||October 3, 2016
    Technology is changing the personal care market

  • Skin Care of One’s Own

    Skin Care of One’s Own

    Christine Esposito, Associate Editor||October 3, 2016
    Nu Skin’s ageLOC Me—which melds the worlds of smart-phone technology, efficacious ingredients and personalization

  • Proof Positive

    Proof Positive

    Christine Esposito, Associate Editor||October 3, 2016
    Testing service providers enable companies to back up their claims and stay in compliance with regulations.